{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:44:20Z","timestamp":1793371460006,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2 TR002379"],"award-info":[{"award-number":["KL2 TR002379"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s40263-025-01162-y","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T12:54:22Z","timestamp":1739624062000},"page":"339-343","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["MDMA-Assisted Therapy for Post-Traumatic Stress Disorder: Regulatory Challenges and a Path Forward"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7062-8192","authenticated-orcid":false,"given":"Balwinder","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"issue":"2","key":"1162_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1017\/S0033291715001981","volume":"46","author":"C Benjet","year":"2016","unstructured":"Benjet C, Bromet E, Karam EG, Kessler RC, McLaughlin KA, Ruscio AM, et al. The epidemiology of traumatic event exposure worldwide: results from the World Mental Health Survey Consortium. Psychol Med. 2016;46(2):327\u201343.","journal-title":"Psychol Med"},{"key":"1162_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-3-030-97802-0_2","volume-title":"Evidence based treatments for trauma-related psychological disorders: a practical guide for clinicians","author":"EJ Mew","year":"2022","unstructured":"Mew EJ, Koenen KC, Lowe SR. Trauma as a public health issue: epidemiology of trauma and trauma-related disorders. In: Schnyder U, Cloitre M, editors. Evidence based treatments for trauma-related psychological disorders: a practical guide for clinicians. Cham: Springer International Publishing; 2022. p. 13\u201340."},{"issue":"8","key":"1162_CR3","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1176\/appi.ajp.20240536","volume":"181","author":"A Shalev","year":"2024","unstructured":"Shalev A, Cho D, Marmar CR. Neurobiology and treatment of post-traumatic stress disorder. Am J Psychiatry. 2024;181(8):705\u201319.","journal-title":"Am J Psychiatry"},{"key":"1162_CR4","unstructured":"Harvard Medical School, 2007. National Comorbidity Survey (NCS). 2017. https:\/\/www.hcp.med.harvard.edu\/ncs\/ftpdir\/NCS-R_Lifetime_Prevalence_Estimates.pdf. Accessed 29 Nov 2024."},{"issue":"9","key":"1162_CR5","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/jamapsychiatry.2015.0803","volume":"72","author":"CR Marmar","year":"2015","unstructured":"Marmar CR, Schlenger W, Henn-Haase C, Qian M, Purchia E, Li M, et al. Course of post-traumatic stress disorder 40 years after the Vietnam War: findings from the National Vietnam Veterans Longitudinal Study. JAMA Psychiat. 2015;72(9):875\u201381.","journal-title":"JAMA Psychiat"},{"issue":"2","key":"1162_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0193-953X(01)00007-7","volume":"25","author":"SP Orr","year":"2002","unstructured":"Orr SP, Metzger LJ, Pitman RK. Psychophysiology of post-traumatic stress disorder. Psychiatr Clin N Am. 2002;25(2):271\u201393.","journal-title":"Psychiatr Clin N Am"},{"issue":"3","key":"1162_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.7326\/M23-2757","volume":"177","author":"PP Schnurr","year":"2024","unstructured":"Schnurr PP, Hamblen JL, Wolf J, Coller R, Collie C, Fuller MA, et al. The management of post-traumatic stress disorder and acute stress disorder: synopsis of the 2023 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Ann Intern Med. 2024;177(3):363\u201374.","journal-title":"Ann Intern Med"},{"issue":"4","key":"1162_CR8","first-page":"26306","volume":"18","author":"B Singh","year":"2016","unstructured":"Singh B, Hughes AJ, Mehta G, Erwin PJ, Parsaik AK. Efficacy of prazosin in post-traumatic stress disorder: a systematic review and meta-analysis. Prim Care Companion CNS Disord. 2016;18(4):26306.","journal-title":"Prim Care Companion CNS Disord."},{"key":"1162_CR9","doi-asserted-by":"crossref","unstructured":"Guideline development panel for the treatment of PTSD in adults APA. Summary of the Clinical Practice Guideline for the Treatment of Post-Traumatic Stress Disorder (PTSD) in Adults. Am Psychol. 2019;74(5):596\u2013607.","DOI":"10.1037\/amp0000473"},{"issue":"12","key":"1162_CR10","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1176\/appi.ajp.20230950","volume":"181","author":"LM Sippel","year":"2024","unstructured":"Sippel LM, Hamblen JL, Kelmendi B, et al. Novel pharmacologic and other somatic treatment approaches for post-traumatic stress disorder in adults: state of the evidence. Am J Psychiatry. 2024;181(12):1045\u201358. https:\/\/doi.org\/10.1176\/appi.ajp.20230950.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"1162_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/JCP.0000000000001898","volume":"44","author":"B Singh","year":"2024","unstructured":"Singh B. Ketamine and esketamine for depression in daily practice: opportunities and challenges. J Clin Psychopharmacol. 2024;44(5):451\u20135.","journal-title":"J Clin Psychopharmacol"},{"key":"1162_CR12","unstructured":"https:\/\/www.prnewswire.com\/news-releases\/maps-public-benefit-corporation-announces-oversubscribed-series-a-financing-and-renames-to-lykos-therapeutics-302026852.html Accessed 12 Dec 2024."},{"key":"1162_CR13","unstructured":"Wang JB, Lin J, Bedrosian L, Coker A, Jerome I, Feduccia A, et al. Scaling up: multisite open-label clinical trials of MDMA-assisted therapy for severe post-traumatic stress disorder. J Humanist Psychol. 00221678211023663."},{"issue":"8","key":"1162_CR14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/ijnp\/pyab026","volume":"24","author":"DB Yaden","year":"2021","unstructured":"Yaden DB, Johnson MW, Griffiths RR, Doss MK, Garcia-Romeu A, Nayak S, et al. Psychedelics and consciousness: distinctions, demarcations, and opportunities. Int J Neuropsychopharmacol. 2021;24(8):615\u201323.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"1162_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1017\/S1461145713001405","volume":"17","author":"RL Carhart-Harris","year":"2014","unstructured":"Carhart-Harris RL, Wall MB, Erritzoe D, Kaelen M, Ferguson B, De Meer I, et al. The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories. Int J Neuropsychopharmacol. 2014;17(4):527\u201340.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1162_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.852248","volume":"13","author":"SM Nayak","year":"2022","unstructured":"Nayak SM, Griffiths RR. A single belief-changing psychedelic experience is associated with increased attribution of consciousness to living and non-living entities. Front Psychol. 2022;13: 852248.","journal-title":"Front Psychol"},{"key":"1162_CR17","unstructured":"Mithoefer MC. A manual for MDMA-assisted psychotherapy in the treatment of post-traumatic stress disorder (v.8.1.). Santa Cruz: Multidisciplinary Association for Psychedelic Studies. 2017. http:\/\/www.maps.org\/research\/mdma\/mdma-research-timeline\/4887-a-manualfor-mdma-assisted-psychotherapy-in-the-treatment-of-ptsd."},{"issue":"4","key":"1162_CR18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/0269881110378371","volume":"25","author":"MC Mithoefer","year":"2011","unstructured":"Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R. The safety and efficacy of +\/-3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant post-traumatic stress disorder: the first randomized controlled pilot study. J Psychopharmacol. 2011;25(4):439\u201352.","journal-title":"J Psychopharmacol"},{"issue":"1","key":"1162_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/0269881112456611","volume":"27","author":"MC Mithoefer","year":"2013","unstructured":"Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B, et al. Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. J Psychopharmacol. 2013;27(1):28\u201339.","journal-title":"J Psychopharmacol"},{"issue":"8","key":"1162_CR20","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41386-024-01865-8","volume":"49","author":"J Colcott","year":"2024","unstructured":"Colcott J, Guerin AA, Carter O, Meikle S, Bedi G. Side-effects of MDMA-assisted psychotherapy: a systematic review and meta-analysis. Neuropsychopharmacology. 2024;49(8):1208\u201326. https:\/\/doi.org\/10.1038\/s41386-024-01865-8.","journal-title":"Neuropsychopharmacology"},{"key":"1162_CR21","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3389\/fpsyt.2019.00650","volume":"10","author":"AA Feduccia","year":"2019","unstructured":"Feduccia AA, Jerome L, Yazar-Klosinski B, Emerson A, Mithoefer MC, Doblin R. Breakthrough for trauma treatment: safety and efficacy of MDMA-assisted psychotherapy compared to paroxetine and sertraline. Front Psychiatry. 2019;10:650.","journal-title":"Front Psychiatry."},{"issue":"6","key":"1162_CR22","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","volume":"27","author":"JM Mitchell","year":"2021","unstructured":"Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med. 2021;27(6):1025\u201333.","journal-title":"Nat Med"},{"issue":"10","key":"1162_CR23","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1038\/s41591-023-02565-4","volume":"29","author":"JM Mitchell","year":"2023","unstructured":"Mitchell JM, Ot\u2019alora GM, van der Kolk B, Shannon S, Bogenschutz M, Gelfand Y, et al. MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial. Nat Med. 2023;29(10):2473\u201380.","journal-title":"Nat Med"},{"issue":"7969","key":"1162_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/d41586-023-02093-8","volume":"619","author":"R Haridy","year":"2023","unstructured":"Haridy R. Australia to prescribe MDMA and psilocybin for PTSD and depression in world first. Nature. 2023;619(7969):227\u20138.","journal-title":"Nature"},{"key":"1162_CR25","doi-asserted-by":"crossref","unstructured":"Reardon S. FDA rejects ecstasy as a therapy: what\u2019s next for psychedelics? Nature. 2024.","DOI":"10.1038\/d41586-024-02597-x"},{"issue":"2","key":"1162_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.resuscitation.2005.01.020","volume":"66","author":"MM Patel","year":"2005","unstructured":"Patel MM, Belson MG, Wright D, Lu H, Heninger M, Miller MA. Methylenedioxymethamphetamine (ecstasy)-related myocardial hypertrophy: an autopsy study. Resuscitation. 2005;66(2):197\u2013202.","journal-title":"Resuscitation"},{"issue":"6","key":"1162_CR27","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1124\/mol.63.6.1223","volume":"63","author":"V Setola","year":"2003","unstructured":"Setola V, Hufeisen SJ, Grande-Allen KJ, Vesely I, Glennon RA, Blough B, et al. 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Mol Pharmacol. 2003;63(6):1223\u20139.","journal-title":"Mol Pharmacol"},{"issue":"11","key":"1162_CR28","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1001\/jamapsychiatry.2024.2887","volume":"81","author":"IA Cristea","year":"2024","unstructured":"Cristea IA, Cuijpers P, Halvorsen JO. The psychotherapy in MDMA-assisted psychotherapy. JAMA Psychiat. 2024;81(11):1053\u20134.","journal-title":"JAMA Psychiat"},{"issue":"18","key":"1162_CR29","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","volume":"387","author":"GM Goodwin","year":"2022","unstructured":"Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, et al. Single-dose psilocybin for a treatment-resistant episode of major depression. N Engl J Med. 2022;387(18):1637\u201348.","journal-title":"N Engl J Med"},{"issue":"3","key":"1162_CR30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/02698811231224153","volume":"38","author":"AK Bershad","year":"2024","unstructured":"Bershad AK, Hsu DT, de Wit H. MDMA enhances positive affective responses to social feedback. J Psychopharmacol. 2024;38(3):297\u2013304.","journal-title":"J Psychopharmacol"},{"key":"1162_CR31","unstructured":"FDA issues first draft guidance on clinical trials with psychedelic drugs | FDA. 2023. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/psychedelic-drugs-considerations-clinical-investigations. Accessed 13 Sept 2024."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01162-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-025-01162-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01162-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T12:30:37Z","timestamp":1741955437000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-025-01162-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1162"],"URL":"https:\/\/doi.org\/10.1007\/s40263-025-01162-y","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"15 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This publication was supported by\u00a0the Clinical and Translational Science Awards (CTSA)\u00a0Grant No. KL2 TR002379 from the National Center for Advancing Translational Science (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the\u00a0National Institutes of Health (NIH).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Dr. Singh has received research grant support from the Mayo Clinic, the National Network of Depression Centers (NNDC), Breakthrough Discoveries for Thriving with Bipolar Disorder (BD2), and the NIH. He is a KL2 Mentored Career Development Program scholar, supported by CTSA grant no. KL2TR002379 from the National Center for Advancing Translational Science (NCATS). Dr. Singh has received honoraria (to Mayo Clinic) from Elsevier for editing a clinical overview on treatment-resistant depression. The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. There is no role of a funding source in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"B.S. was responsible for concept and design, drafting of the manuscript, and critical revision of the manuscript for important intellectual content. The author agrees to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}